Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yousra Kherabi

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
NEJM Evidence|February 6, 2024
Statistics of Rare EventsMichael A Proschan, Yousra Kherabi
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future?Yousra Kherabi, Jonathan Messika, Nathan Peiffer-Smadja
Pathogens (Basel, Switzerland)|October 27, 2022
Preventive Therapy for Contacts of Drug-Resistant TuberculosisYousra Kherabi, Simone Tunesi, Alexander Kay, et al.
Clinical Trials (London, England)|February 25, 2026
Response-adaptive randomization with imperfect intermediate endpointsYousra Kherabi, Michael A Proschan, Lori E Dodd
Viruses|October 27, 2022
COVID-19 Vaccines against Omicron Variant: Real-World Data on EffectivenessYousra Kherabi, Odile Launay, Liem Binh Luong Nguyen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in EuropeGunar Günther, Lorenzo Guglielmetti, Yousra Kherabi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2022
Re: 'clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection' by Mailhe et alYousra Kherabi, Liem Binh Luong Nguyen, Frédéric Batteux, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's responseChristoph Lange, Yousra Kherabi, Lorenzo Guglielmetti, et al.
Cancers|February 11, 2023
Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-AnalysisSylvain Bodard, Yan Liu, Sylvain Guinebert, et al.
Cancers|April 13, 2023
Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/LymphomasBenoît Pilmis, Yousra Kherabi, Pauline Huriez, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
NEJM Evidence|February 6, 2024
Statistics of Rare EventsMichael A Proschan, Yousra Kherabi
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future?Yousra Kherabi, Jonathan Messika, Nathan Peiffer-Smadja
Pathogens (Basel, Switzerland)|October 27, 2022
Preventive Therapy for Contacts of Drug-Resistant TuberculosisYousra Kherabi, Simone Tunesi, Alexander Kay, et al.
Clinical Trials (London, England)|February 25, 2026
Response-adaptive randomization with imperfect intermediate endpointsYousra Kherabi, Michael A Proschan, Lori E Dodd
Viruses|October 27, 2022
COVID-19 Vaccines against Omicron Variant: Real-World Data on EffectivenessYousra Kherabi, Odile Launay, Liem Binh Luong Nguyen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in EuropeGunar Günther, Lorenzo Guglielmetti, Yousra Kherabi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2022
Re: 'clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection' by Mailhe et alYousra Kherabi, Liem Binh Luong Nguyen, Frédéric Batteux, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's responseChristoph Lange, Yousra Kherabi, Lorenzo Guglielmetti, et al.
Cancers|February 11, 2023
Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-AnalysisSylvain Bodard, Yan Liu, Sylvain Guinebert, et al.
Cancers|April 13, 2023
Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/LymphomasBenoît Pilmis, Yousra Kherabi, Pauline Huriez, et al.
Pageof 5